Dihydropyridine calcium channel blocker drugs – felodipine

Last updated on October 6, 2022

Generic name

felodipine                                                                                                                                               
Strength

2.5 mg, 5 mg, 10 mg

Form

extended release tablet

Special Authority criteria

Approval period

  1. Treatment failure on optimal doses of, or intolerance to, amlodipine.

      OR

  1. Complex patient requiring medications for co-existing chronic condition(s).

Indefinite

Practitioner exemptions

  • Practitioners in the following specialty are not required to submit a Special Authority request form for coverage:
    • Cardiologists
    • Cardiovascular and Thoracic Surgery
    • Internists specializing in cardiology
    • Nephrologists
    • Paediatrics
    • Paediatric Cardiology

Special notes

  • Patients with co-existing chronic conditions requiring use of multiple medications will be considered complex for the purposes of Special Authority criteria.

Special Authority request form(s)